{
 "url": "https://etfiq.com/funds/ibbq/holdings/",
 "section": "funds",
 "title": "IBBQ Holdings: 255 Positions (Oct 13, 2026) | ETFIQ",
 "description": "IBBQ holdings as of Oct 13, 2026: GILD 8.51%, AMGN 8.09% and VRTX 7.51% and 252 more. See every weight, the cash row and the source, or download the CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "IBBQ",
 "fund": "Invesco Nasdaq Biotechnology ETF",
 "fund_page": "https://etfiq.com/funds/ibbq",
 "positions": 255,
 "positions_listed_on_page": 250,
 "lead": "IBBQ held 255 positions as of Oct 13, 2026. Gilead Sciences Inc is the largest at 8.51%; the top 10 are 47.1% of the fund.",
 "source": {
  "name": "Invesco",
  "url": "https://dng-api.invesco.com/cache/v1/accounts/en_US/shareclasses/46138G599/holdings/fund?idType=cusip&productType=ETF",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Gilead Sciences Inc",
   "ticker": "GILD",
   "weight_pct": 8.511,
   "page": "https://etfiq.com/holdings/gild/"
  },
  {
   "rank": 2,
   "holding": "Amgen Inc",
   "ticker": "AMGN",
   "weight_pct": 8.094,
   "page": "https://etfiq.com/holdings/amgn/"
  },
  {
   "rank": 3,
   "holding": "Vertex Pharmaceuticals Inc",
   "ticker": "VRTX",
   "weight_pct": 7.509,
   "page": "https://etfiq.com/holdings/vrtx/"
  },
  {
   "rank": 4,
   "holding": "Moderna Inc",
   "ticker": "MRNA",
   "weight_pct": 5.952,
   "page": "https://etfiq.com/holdings/mrna/"
  },
  {
   "rank": 5,
   "holding": "Regeneron Pharmaceuticals Inc",
   "ticker": "REGN",
   "weight_pct": 5.245,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 6,
   "holding": "Illumina Inc",
   "ticker": "ILMN",
   "weight_pct": 2.824,
   "page": "https://etfiq.com/holdings/ilmn/"
  },
  {
   "rank": 7,
   "holding": "Revolution Medicines Inc",
   "ticker": "RVMD",
   "weight_pct": 2.783,
   "page": "https://etfiq.com/holdings/rvmd/"
  },
  {
   "rank": 8,
   "holding": "Biogen Inc",
   "ticker": "BIIB",
   "weight_pct": 2.332,
   "page": "https://etfiq.com/holdings/biib/"
  },
  {
   "rank": 9,
   "holding": "Alnylam Pharmaceuticals Inc",
   "ticker": "ALNY",
   "weight_pct": 2.065,
   "page": "https://etfiq.com/holdings/alny/"
  },
  {
   "rank": 10,
   "holding": "Royalty Pharma PLC",
   "ticker": "RPRX",
   "weight_pct": 1.737,
   "page": "https://etfiq.com/holdings/rprx/"
  },
  {
   "rank": 11,
   "holding": "Roivant Sciences Ltd",
   "ticker": "ROIV",
   "weight_pct": 1.66,
   "page": "https://etfiq.com/holdings/roiv/"
  },
  {
   "rank": 12,
   "holding": "United Therapeutics Corp",
   "ticker": "UTHR",
   "weight_pct": 1.609,
   "page": "https://etfiq.com/holdings/uthr/"
  },
  {
   "rank": 13,
   "holding": "Incyte Corp",
   "ticker": "INCY",
   "weight_pct": 1.518,
   "page": "https://etfiq.com/holdings/incy/"
  },
  {
   "rank": 14,
   "holding": "Argenx SE",
   "ticker": "ARGX",
   "weight_pct": 1.503,
   "page": "https://etfiq.com/holdings/argx/"
  },
  {
   "rank": 15,
   "holding": "Guardant Health Inc",
   "ticker": "GH",
   "weight_pct": 1.499,
   "page": "https://etfiq.com/holdings/gh/"
  },
  {
   "rank": 16,
   "holding": "Insmed Inc",
   "ticker": "INSM",
   "weight_pct": 1.457,
   "page": "https://etfiq.com/holdings/insm/"
  },
  {
   "rank": 17,
   "holding": "Viatris Inc",
   "ticker": "VTRS",
   "weight_pct": 1.365,
   "page": "https://etfiq.com/holdings/vtrs/"
  },
  {
   "rank": 18,
   "holding": "Medpace Holdings Inc",
   "ticker": "MEDP",
   "weight_pct": 1.166,
   "page": "https://etfiq.com/holdings/medp/"
  },
  {
   "rank": 19,
   "holding": "Exelixis Inc",
   "ticker": "EXEL",
   "weight_pct": 1.016,
   "page": "https://etfiq.com/holdings/exel/"
  },
  {
   "rank": 20,
   "holding": "Ascendis Pharma A/S",
   "ticker": "ASND",
   "weight_pct": 0.946,
   "page": null
  },
  {
   "rank": 21,
   "holding": "Neurocrine Biosciences Inc",
   "ticker": "NBIX",
   "weight_pct": 0.946,
   "page": "https://etfiq.com/holdings/nbix/"
  },
  {
   "rank": 22,
   "holding": "Jazz Pharmaceuticals PLC",
   "ticker": "JAZZ",
   "weight_pct": 0.941,
   "page": "https://etfiq.com/holdings/jazz/"
  },
  {
   "rank": 23,
   "holding": "Bridgebio Pharma Inc",
   "ticker": "BBIO",
   "weight_pct": 0.874,
   "page": "https://etfiq.com/holdings/bbio/"
  },
  {
   "rank": 24,
   "holding": "BeOne Medicines Ltd",
   "ticker": "ONC",
   "weight_pct": 0.86,
   "page": "https://etfiq.com/holdings/onc/"
  },
  {
   "rank": 25,
   "holding": "Halozyme Therapeutics Inc",
   "ticker": "HALO",
   "weight_pct": 0.857,
   "page": "https://etfiq.com/holdings/halo/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash & Equivalents",
   "weight_pct": 0.009
  },
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.002
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/ibbq/holdings/ibbq-holdings.csv",
 "json_book": "https://etfiq.com/data/books/ibbq.json",
 "markdown": "https://etfiq.com/funds/ibbq/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of IBBQ, data as of Oct 13, 2026. https://etfiq.com/funds/ibbq/holdings/"
}